Ex vivo functional analysis, expansion and adoptive transfer of cytomegalovirus-specific T-cells in patients with glioblastoma multiforme.
about
The progress of immunotherapy for glioblastomaImmune regulation of human herpesviruses and its implications for human transplantationCytomegalovirus in human brain tumors: Role in pathogenesis and potential treatment optionsAn update on vaccine therapy and other immunotherapeutic approaches for glioblastomaT cell engineering as therapy for cancer and HIV: our synthetic futureNovel drugs in pediatric gliomas.Recognition and killing of autologous, primary glioblastoma tumor cells by human cytomegalovirus pp65-specific cytotoxic T cells.The Viral Connection to Glioblastoma.Prioritization schema for immunotherapy clinical trials in glioblastoma.Engineering T cells for cancer: our synthetic future.Current and future directions for Phase II trials in high-grade glioma.Cytomegalovirus and glioma: putting the cart before the horse.A new hope in immunotherapy for malignant gliomas: adoptive T cell transfer therapy.Cytomegalovirus as a novel target for immunotherapy of glioblastoma multiforme.Human cytomegalovirus antigens in malignant gliomas as targets for adoptive cellular therapyCytomegalovirus and glioblastoma; controversies and opportunities.Immunotherapeutic advancements for glioblastoma.Cytomegalovirus and immunotherapy: opportunistic pathogen, novel target for cancer and a promising vaccine vector.Cytomegalovirus-targeted immunotherapy and glioblastoma: hype or hope?Patient-derived glioblastoma stem cells are killed by CD133-specific CAR T cells but induce the T cell aging marker CD57.Adoptive cellular immunotherapy for virus-associated cancers: a new paradigm in personalized medicine.BK Polyomavirus: Clinical Aspects, Immune Regulation, and Emerging Therapies.The Potential of Cellular- and Viral-Based Immunotherapies for Malignant Glioma-Dendritic Cell Vaccines, Adoptive Cell Transfer, and Oncolytic Viruses.Effects of valganciclovir as an add-on therapy in patients with cytomegalovirus-positive glioblastoma: a randomized, double-blind, hypothesis-generating study.Sequence homology between HLA-bound cytomegalovirus and human peptides: A potential trigger for alloreactivity.Clinically significant CMV (re)activation during or after radiotherapy/chemotherapy of the brain : Correlation with neurological deterioration and improvement upon antiviral treatment.Frequent occurrence of therapeutically reversible CMV-associated encephalopathy during radiotherapy of the brain.Increased infiltration and tolerised antigen-specific CD8+ TEM cells in tumor but not peripheral blood have no impact on survival of HCMV+ glioblastoma patients.Cellular immunotherapy directed against human cytomegalovirus as a novel approach for glioblastoma treatment.Immunological targeting of cytomegalovirus for glioblastoma therapy.Phenotypic and transcriptional profile correlates with functional plasticity of antigen-specific CD4+ T cells.Immunology and Cell Biology Publication of the Year Awards 2012.Dendritic Cells Enhance Polyfunctionality of Adoptively Transferred T Cells That Target Cytomegalovirus in Glioblastoma.New extracellular factors in glioblastoma multiforme development: neurotensin, growth differentiation factor-15, sphingosine-1-phosphate and cytomegalovirus infection.Dexamethasone-induced immunosuppression: mechanisms and implications for immunotherapy.The impact of inflationary cytomegalovirus-specific memory T cells on anti-tumour immune responses in patients with cancer
P2860
Q26797282-19F39BAE-EEC3-4AEC-87CC-BD1AAC7A81E8Q26992146-577D0A39-3E9F-4DCA-98E2-354BFB32B04DQ26996612-C5CFBD18-2F3E-4C3D-9A05-EA594237B642Q27024830-F54D24F2-D3EB-471C-9942-87D7C548FBF1Q28082253-FFEF0F02-E860-471D-B0B5-B9378A95715BQ33685551-E6DBFB89-4B5C-4D09-8725-14BB97168CA6Q33761585-E7DBDEE8-8CE2-4B64-9E35-9F1BC5AFE019Q34552036-567FE376-B81A-4F4C-A3FF-E3BF23A2E107Q37078999-FC2D7111-1620-46EC-9337-D0A77349B77AQ37515502-7E11D54A-FBB8-400A-A1D9-8F0CE17ADF43Q38094808-2B5CF5B4-0AB7-4AF0-8E80-F944635BA1C8Q38218302-464ECDE5-D208-4880-80FD-C672E04AC443Q38227889-F8C72AB8-1B68-4C82-B744-75C3EBDCB881Q38262132-D42E36E3-4844-4ACF-AC83-D7C094EAF473Q38288049-A5596AB7-7237-435C-BDA5-01B47BE60D2EQ38355706-B415040B-7412-4B0B-9BF5-F2CDFA0B0A3DQ38358124-E16616A9-B313-4CB6-9BDD-71FCE7E3A0B5Q38703382-33206814-960C-43F9-B286-D1902CF29C38Q38773347-FAF1D8F4-0E04-4768-A79B-513A8FC2FDDFQ38937646-5C457D48-C179-4F47-ACC2-2D72AE02FB7AQ39044990-3CAF3F23-0E47-4D10-9707-A8E70BED35F7Q39180715-589BD470-6EB2-44B7-85AF-879406E9EF33Q39294814-A3C2D833-8155-4765-AD00-FECE53D9C330Q39468197-F1C62DC1-20DB-4AD0-9AE8-AFB4089509FEQ40096975-622907D6-753D-42FC-AE14-1F96CDEE05EFQ40651359-027215E6-8AF1-4FF8-BCE0-D4F07193E455Q40707851-A006BDFC-88C8-4E65-9774-FDE9F4A63127Q41338250-54AF77E0-F5CD-488A-BB17-60C4C1BD918AQ41961885-6C253D6B-FDE6-4C94-9A1A-DC44931834E0Q42007228-A0CBEA4C-B56C-4266-963B-8070D1087A1BQ42238387-E8ADE54A-8330-4883-A3C8-3857B57DA648Q44997159-5F8036ED-D4E4-41EE-AB7E-3FD3F5C2967EQ47674203-29D8CE5C-CD1F-4FB3-99DC-932500EEF2D0Q52691329-B9A803BF-14BF-4D45-93C3-1DA2308AF4BFQ55283310-293EA3F1-8098-40D4-9A83-AACE01FD31BBQ58484770-F3743C62-EAD0-4CFE-8E5D-289D7888D02A
P2860
Ex vivo functional analysis, expansion and adoptive transfer of cytomegalovirus-specific T-cells in patients with glioblastoma multiforme.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Ex vivo functional analysis, e ...... with glioblastoma multiforme.
@en
Ex vivo functional analysis, e ...... with glioblastoma multiforme.
@nl
type
label
Ex vivo functional analysis, e ...... with glioblastoma multiforme.
@en
Ex vivo functional analysis, e ...... with glioblastoma multiforme.
@nl
prefLabel
Ex vivo functional analysis, e ...... with glioblastoma multiforme.
@en
Ex vivo functional analysis, e ...... with glioblastoma multiforme.
@nl
P2093
P2860
P356
P1476
Ex vivo functional analysis, e ...... with glioblastoma multiforme.
@en
P2093
Corey Smith
David G Walker
Leone Beagley
Linda Jones
Tania Crough
P2860
P2888
P304
P356
10.1038/ICB.2012.19
P50
P577
2012-04-17T00:00:00Z
P5875
P6179
1049262742